Company profile
ARTIVION, INC.
NYSE:AORTMedical/Dental Instruments
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04142658 | phase3 | terminated | 2020-05-01 | 2022-12-12 | Artivion Inc. | PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban |
FDA applications (0)
No records yet.